ARCHIVES

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

This article is from The Cancer Letter archive.

Vol. 38 No. 17 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Shortage Of Patients In Right Place, Time Develops As Major Problem For Investigators

May 3, 1974

Seattle Cancer Care Alliance Marks its 10th Anniversary—January 2011

June 28, 2021

House Appropriator Claims NCI, NLM Grants Funded Political Activity, Seeks OIG Probe

March 22, 2013

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

June 24, 2005

National Academies: Changes Required To Reduce Incidence Of Medical Errors, Report Finds

December 3, 1999

FDA Guidance for Public Comment at Advisory Committee Meetings

December 10, 2010